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INTRODUCTION 
 
Continuous separation of mixtures of immiscible liquids featuring different wettability 
properties can be achieved using microporous membranes. However, in order to 
achieve common industrial acceptance, this technology must demonstrate factual 
scalability and robustness in operation under realistic (and thus challenging) 
operating scenarios. It is the purpose of this paper to demonstrate the applicability of 
a mini-scale hydrophobic membrane based separator for the continuous hydrolysis 
and liquid-liquid (L-L) separation of an organic and aqueous mixture, while critically 
evaluating the practical operability and limitations of micro/mini-scale-based L-L 
separators in the context of continuous pharmaceutical manufacturing (CPM).  
  
PROCESS DESCRIPTION 
 
The synthesis of cis-zuclopenthixol – a product of H. Lundbeck A/S – is studied. The 
manufacturing process consists of the process steps described in Figure 1. The 
paper will focus on the continuous hydrolysis of the alkoxide product obtained from a 
continuous Grignard alkylation reaction and especially on the subsequent continuous 
separation of the organic and aqueous phases.  
 
 
 
Figure 1: Schematic description of the production process (CTX - 2-Chlorthioxanthen-9-one;                 
GR - Grignard reagent; THF - Tetrahydrofuran; Allylcarbinol - 9-Allyl-2-Chlorothioxanthen-9-Ol 9H-thio 
xanthen-9-ol; Butadiene -    
 
Continuous hydrolysis of the alkoxide product 
 
The alkoxide (unhydrolized allylcarbinol) dissolved in THF reacts with water 
containing a small amount of HCl. This reaction is performed in a 1/8 inch PTFE tube 
reactor using a T-connection from which segmented flow is generated. The reaction 
is exothermic and the heat is released using a water bath. The alkoxide is hydrolized 
while producing Mg salts which are solubilised by HCl forming MgCl2. The amount of 
water is regulated so that the Mg salt concentration is below saturation, thereby 
decreasing the risk of blockage due to precipitation of these salts. 
 
Continuous L-L separation 
 
The hydrolysis reaction forms an organic phase and an aqueous phase which are 
immiscible thanks to the salting-out effect caused by the Mg salts. Otherwise the two 
solvents (THF and water) would be totally miscible. In our case study the phases 
have similar densities, and therefore separation by decantation would require 
prohibitively long settling times, while having a non-perfect phase separation. 
Therefore a PTFE membrane mini-separator based on capillarity and surface tension 
differences [1] was developed and tested. A plate coalescer has also been built, and 
the performance obtained with the two separation devices in terms of operability and 
flexibility has been compared [1]. The PTFE membrane mini-separator provided a 
perfect separation of the organic and aqueous mixtures at all concentrations tested, 
for different flow rates and flow ratios of the alkoxide solution and the acidic water 
solution. The concentration of the active pharmaceutical ingredient was measured by 
HPLC in both the organic and aqueous phases, while the amount of water in the 
organic phase and the concentration of THF in the aqueous phase were measured 
using at-line near-infrared (NIR) spectroscopy measurements. The results indicate 
that not only a perfect separation of the API is obtained in the organic phase, but also 
a slight decrease in the amount of water in the organic phase is obtained thanks to 
the hydrophobic membrane.   
 
CONCLUSIONS 
 
Micro-scale technology can be extremely helpful when establishing a continuous 
pharmaceutical production process, but it must be optimally combined with 
mini/meso-scale reactors/separators when required. A mini-scale PTFE membrane 
separator was built enabling the continuous hydrolysis and separation of an organic 
solution containing an API, and an aqueous solution containing Mg salts. Some of 
the flow rates used and the conditions of the experiment are very much alike the 
ones required for industrial scale production. Therefore only a small effort is expected 
to scale-up/out this process, which is by far one of the major advantages of this 
technology.  
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